Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
Silvana Vasile, Anders Hallberg, Jessica Sallander, et al.
Biomolecules (2020) Vol. 10, Iss. 4, pp. 649-649
Open Access | Times Cited: 19

Showing 19 citing articles:

The Angiotensin AT2Receptor: From a Binding Site to a Novel Therapeutic Target
U. Muscha Steckelings, Robert E. Widdop, Edward D. Sturrock, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 1051-1135
Open Access | Times Cited: 50
GPCR drug discovery: new agents, targets and indications
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling
Naureen Fatima, Sanket Patel, Tahir Hussain
Hypertension (2021) Vol. 77, Iss. 6, pp. 1845-1856
Open Access | Times Cited: 49
Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety
Sizhu Gong, Fang Deng
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 15
Current understanding of the link between angiotensin-converting enzyme and pain perception
Kiran D. Bhilare, Prakashkumar Dobariya, Filip Hanak, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104089-104089
Closed Access | Times Cited: 3
Unraveling the relationship between the renin–angiotensin system and endometrial cancer: a comprehensive review
Nihad Ashraf Khan, Deena Elsori, Gowhar Rashid, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD
Dan Mei, W.S. Daniel Tan, Wupeng Liao, et al.
Pharmacological Research (2020) Vol. 161, pp. 105223-105223
Open Access | Times Cited: 16
Update on Angiotensin II Subtype 2 Receptor: Focus on Peptide and Nonpeptide Agonists
Arina Ranjit, Sana Khajehpour, Ali Aghazadeh‐Habashi
Molecular Pharmacology (2021) Vol. 99, Iss. 6, pp. 469-487
Open Access | Times Cited: 14
Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure
Sukhwinder K. Bhullar, Naranjan S. Dhalla
Canadian Journal of Physiology and Pharmacology (2023) Vol. 102, Iss. 2, pp. 86-104
Open Access | Times Cited: 5
Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways
Wenxin Luo, Yilin Gu, Siyu Fu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115762-115762
Closed Access | Times Cited: 4
Fuyuan Xingnao Decoction Promotes Angiogenesis Through the Rab1/AT1R Pathway in Diabetes Mellitus Complicated With Cerebral Infarction
Dongmei Deng, Yao Qu, Lihua Sun, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 7
Anti-diarrheal therapeutic potential of diminazene aceturate stimulation of the ACE II/Ang-(1–7)/Mas receptor axis in mice: A trial study
Luan Kelves Miranda de Souza, Kerolayne de Melo Nogueira, Thiago S.L. Araújo, et al.
Biochemical Pharmacology (2021) Vol. 186, pp. 114500-114500
Closed Access | Times Cited: 5
Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds
Greeshma Gopalan, Carlos Palo‐Nieto, Nadia Nasser Petersen, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 65, pp. 116790-116790
Open Access | Times Cited: 3
Modulator Effect of AT1 Receptor Knockdown on THP-1 Macrophage Proinflammatory Activity
Lourdes Nallely Acevedo-Villavicencio, Carlos Enrique López‐Luna, Juan Castillo-Cruz, et al.
Biology (2024) Vol. 13, Iss. 6, pp. 382-382
Open Access
Peptide Drug Design Using Alchemical Free Energy Calculation: An Application and Validation on Agonists of Ghrelin Receptor
Qin Zeng, Guangpeng Meng, Bingyu Zhao, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 12, pp. 4863-4876
Closed Access
Peptidomimetics design and characterization: Bridging experimental and computer-based approaches
Alice Romagnoli, Jesmina Rexha, Nunzio Perta, et al.
Progress in molecular biology and translational science (2024), pp. 279-327
Closed Access
Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stability
Dirk Tourwé, Antonis D. Tsiailanis, Nikolaos A. Parisis, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 43, pp. 128086-128086
Open Access | Times Cited: 2
The SARS-CoV2 - ACE2 link: a physiopathological analysis
Eugen Petcu, Chris Andry, Eric Burks, et al.
Vascular Cell (2020) Vol. 12, Iss. 1
Open Access
Renin-angiotensin System: A New Promising Therapeutic and Mechanisms for Depression and Anxiety
Sizhu Gong, fang deng
Authorea (Authorea) (2022)
Open Access
Page 1

Scroll to top